Oral health challenges in pediatric oncology patients

Raed Mohammed Alamoudi; Abdullah Hamad Alzaid; Shihnaz Mohammed Algarni; Remaz Mohammed Ballaji; Abdullah Emad Alsaadawi; Anas Abdulrazaq Shiku; Sara Mohammed Aljohani; Sumayah Abdulbaqi Mohammad; Nasser Ibrahim Alreshoodi; Abdullah Mohammed Alhussain; Asma Habib Alnakhli

doi:10.18203/2394-6040.ijcmph20242898

Authors

Raed Mohammed Alamoudi Department of Pediatric Dentistry, Al Thager Hospital, Jeddah, Saudi Arabia
Abdullah Hamad Alzaid Department of Pediatric Dentistry, Ministry of Health, Riyadh, Saudi Arabia
Shihnaz Mohammed Algarni Dental Department, National Guard Health Affairs (NGHA), Dammam, Saudi Arabia
Remaz Mohammed Ballaji Dental Department, Private Clinic, Medina, Saudi Arabia
Abdullah Emad Alsaadawi Department of Pediatric Dentistry, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia
Anas Abdulrazaq Shiku Dental Department, Makkah Health Cluster, Mecca, Saudi Arabia
Sara Mohammed Aljohani Dental Department, Armed Forces Hospital, Khamis Mushait, Saudi Arabia
Sumayah Abdulbaqi Mohammad Dental Department, Ministry of Health, Al Ahsa, Saudi Arbia
Nasser Ibrahim Alreshoodi College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Abdullah Mohammed Alhussain Department of Pediatric Dentistry, National Guard Health Affairs (NGHA), Riyadh, Saudi Arabia
Asma Habib Alnakhli Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20242898

Keywords:

Pediatric oncology, Oral health, Mucositis, Xerostomia, Interdisciplinary care

Abstract

Pediatric oncology patients face significant oral health challenges due to the adverse effects of chemotherapy and radiation therapy. These treatments, while essential for cancer management, often lead to complications such as mucositis, xerostomia, and increased susceptibility to oral infections. Mucositis, characterized by painful inflammation and ulceration of the oral mucosa, can severely impact a child’s ability to eat, speak, and maintain oral hygiene, leading to additional health complications and potential interruptions in cancer treatment. Xerostomia, or dry mouth, resulting from radiation damage to salivary glands, further exacerbates the risk of dental caries, periodontal disease, and oral infections, diminishing the child’s quality of life. Preventive strategies, including pre-treatment dental evaluations, regular oral hygiene, and the use of fluoride treatments, play a crucial role in minimizing these complications. Management approaches such as cryotherapy and low-level laser therapy have shown promise in reducing the severity of mucositis, while saliva stimulants and substitutes help alleviate xerostomia symptoms. Additionally, a multidisciplinary approach involving oncologists, dentists, nurses, and dietitians is essential for comprehensive care. Early dental intervention, continuous monitoring of oral health, and tailored nutritional support are key components of this collaborative model. Addressing oral health in pediatric cancer patients not only reduces discomfort but also supports better treatment adherence and outcomes. The integration of preventive and therapeutic strategies into cancer care can improve the overall well-being of these patients, highlighting the importance of interdisciplinary collaboration in managing the complex oral health challenges that arise during cancer treatment. This approach ensures that oral complications are addressed promptly and effectively, ultimately enhancing the quality of life and long-term health of pediatric oncology patients.

Metrics

Metrics Loading ...

References

Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004;2(6-3):3-8.

Cheng KK-F, Leung S, Liang RH, Tai JW, Yeung RM, Thompson DR. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer. 2010;18(11):1477-85.

Supportive P, Board PCE. Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®). In: PDQ Cancer Information Summaries. National Cancer Institute (US). 2022.

Hancock PJ, Epstein JB, Sadler GB. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc. 2003;69(9):585-90.

Cheng KKF, Lee V, Li CH, Yuen HL, Epstein JB. Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer. 2012;20(10):2335-42.

Jensen S, Pedersen A, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039-60.

Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-20.

Vahidi N, Lee TS, Daggumati S, Shokri T, Wang W, Ducic Y. Osteoradionecrosis of the midface and mandible: pathogenesis and management. Semin Plast Surg. 2020;34(4):232-44.

Cheng KK, Goggins WB, Lee VW, Thompson DR. Risk factors for oral mucositis in children undergoing chemotherapy: a matched case-control study. Oral Oncol. 2008;44(11):1019-25.

Peterson D, Bensadoun R-J, Roila F. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(6):vi78-84.

Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncol. 2019;95:29-34.

Hong CH, Hu S, Haverman T, Monique S, Joel JN, Den Braber JB, et al. A systematic review of dental disease management in cancer patients. Support Care Cancer. 2018;26(1):155-74.

Cawley MM, Benson LM. Current trends in managing oral mucositis. Clin J Oncol Nurs. 2005;9(5):584-92.

Lalla RV, Bowen JM. Mucositis (oral and gastrointestinal). The MASCC textbook of cancer supportive care and survivorship. 2018;409-20.